- Patent Title: Recombinant cytomegalovirus vectors as vaccines for tuberculosis
-
Application No.: US17365509Application Date: 2021-07-01
-
Publication No.: US11834669B2Publication Date: 2023-12-05
- Inventor: Thomas G. Evans , Ravi Anantha , Aurelio M. Bonavia , Dominick J. Laddy , Louis Picker , Scott Hansen , Guangwu Xu
- Applicant: International AIDS Vaccine Initiative, Inc. , Oregon Health and Science University
- Applicant Address: US NY New York
- Assignee: International AIDS Vaccine Initiative, Inc.,Oregon Health and Science University
- Current Assignee: International AIDS Vaccine Initiative, Inc.,Oregon Health and Science University
- Current Assignee Address: US NY New York; US OR Portland
- Agency: Armstrong Teasdale LLP
- Main IPC: C12N15/86
- IPC: C12N15/86 ; A61K39/04 ; C07K14/35 ; A61K39/00
Abstract:
Disclosed herein are cytomegalovirus vectors encoding fusion proteins comprising Mycobacterium tuberculosis (Mtb) antigens, nucleic acid molecules encoding the same, cytomegalovirus vectors comprising nucleic acid molecules, compositions comprising the same, and methods of eliciting an immune response against tuberculosis.
Public/Granted literature
- US20210403951A1 Recombinant Cytomegalovirus Vectors As Vaccines For Tuberculosis Public/Granted day:2021-12-30
Information query
IPC分类:
